Key result
Pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve was successfully performed in a patient with a large native RVOT, with no complications during the hospital stay.
Why the study?
Creating a stable landing zone smaller than the largest available valve is crucial for PPVI success, limiting suitable candidates with large native RVOT.
Is pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve feasible and safe in a patient with a large native RVOT after surgically corrected Tetralogy of Fallot?
Comparison
PPVI with a 32 mm Myval transcatheter heart valve
Design
Case report
Follow-up
Hospital stay
Authors
Loading...
Successful single-case implantation supports feasibility in large native RVOT; hypothesis-generating and requires prospective validation before broader use.
Case Report (n=1)
Is pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve feasible and safe in a patient with a large native RVOT after surgically corrected Tetralogy of Fallot?
Pulmonary percutaneous valve implantation using a 32 mm Myval transcatheter heart valve is feasible and safe in patients with a large native RVOT following surgically corrected Tetralogy of Fallot.
Ogando et al. (2021) conducted a case report in Large native right ventricular outflow tract (RVOT) lesion after surgically corrected Tetralogy of Fallot (n=1). Pulmonary percutaneous valve implantation (PPVI) with a 32 mm Myval transcatheter heart valve was evaluated on Post-procedural outcomes and complications during hospital stay. Pulmonary percutaneous valve implantation with a 32 mm Myval transcatheter heart valve was successfully performed in a patient with a large native RVOT, with no complications during the hospital stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: